158 related articles for article (PubMed ID: 38762174)
1. CK2-HTATSF1-TOPBP1 signaling axis modulates tumor chemotherapy response.
Guo Q; Zhao J; Li Y; Zhang C; Shen X; Liu L; Yang Z; Ma S; Qin Y; Shi L
J Biol Chem; 2024 May; 300(6):107377. PubMed ID: 38762174
[TBL] [Abstract][Full Text] [Related]
2. A PARylation-phosphorylation cascade promotes TOPBP1 loading and RPA-RAD51 exchange in homologous recombination.
Zhao J; Tian S; Guo Q; Bao K; Yu G; Wang X; Shen X; Zhang J; Chen J; Yang Y; Liu L; Li X; Hao J; Yang N; Liu Z; Ai D; Yang J; Zhu Y; Yao Z; Ma S; Zhang K; Shi L
Mol Cell; 2022 Jul; 82(14):2571-2587.e9. PubMed ID: 35597237
[TBL] [Abstract][Full Text] [Related]
3. Disrupting PHF8-TOPBP1 connection elicits a breast tumor-specific vulnerability to chemotherapeutics.
Ma S; Zhang J; Guo Q; Cao C; Bao K; Liu L; Chen CD; Liu Z; Yang J; Yang N; Yao Z; Shi L
Cancer Lett; 2022 Apr; 530():29-44. PubMed ID: 35051531
[TBL] [Abstract][Full Text] [Related]
4. CK2 Phosphorylation of Human Papillomavirus 16 E2 on Serine 23 Promotes Interaction with TopBP1 and Is Critical for E2 Interaction with Mitotic Chromatin and the Viral Life Cycle.
Prabhakar AT; James CD; Das D; Otoa R; Day M; Burgner J; Fontan CT; Wang X; Glass SH; Wieland A; Donaldson MM; Bristol ML; Li R; Oliver AW; Pearl LH; Smith BO; Morgan IM
mBio; 2021 Oct; 12(5):e0116321. PubMed ID: 34544280
[TBL] [Abstract][Full Text] [Related]
5. TOPBP1 regulates RAD51 phosphorylation and chromatin loading and determines PARP inhibitor sensitivity.
Moudry P; Watanabe K; Wolanin KM; Bartkova J; Wassing IE; Watanabe S; Strauss R; Troelsgaard Pedersen R; Oestergaard VH; Lisby M; Andújar-Sánchez M; Maya-Mendoza A; Esashi F; Lukas J; Bartek J
J Cell Biol; 2016 Feb; 212(3):281-8. PubMed ID: 26811421
[TBL] [Abstract][Full Text] [Related]
6. Chromodomain helicase DNA-binding protein 4 (CHD4) regulates homologous recombination DNA repair, and its deficiency sensitizes cells to poly(ADP-ribose) polymerase (PARP) inhibitor treatment.
Pan MR; Hsieh HJ; Dai H; Hung WC; Li K; Peng G; Lin SY
J Biol Chem; 2012 Feb; 287(9):6764-72. PubMed ID: 22219182
[TBL] [Abstract][Full Text] [Related]
7. RAD51-Mediated DNA Homologous Recombination Is Independent of
Sinha A; Saleh A; Endersby R; Yuan SH; Chokshi CR; Brown KR; Kuzio B; Kauppinen T; Singh SK; Baker SJ; McKinnon PJ; Katyal S
Cancers (Basel); 2020 Oct; 12(11):. PubMed ID: 33138032
[TBL] [Abstract][Full Text] [Related]
8. A phosphorylation-deubiquitination cascade regulates the BRCA2-RAD51 axis in homologous recombination.
Luo K; Li L; Li Y; Wu C; Yin Y; Chen Y; Deng M; Nowsheen S; Yuan J; Lou Z
Genes Dev; 2016 Dec; 30(23):2581-2595. PubMed ID: 27941124
[TBL] [Abstract][Full Text] [Related]
9. Human Papillomavirus 16 E2 Interaction with TopBP1 Is Required for E2 and Viral Genome Stability during the Viral Life Cycle.
Prabhakar AT; James CD; Fontan CT; Otoa R; Wang X; Bristol ML; Hill RD; Dubey A; Morgan IM
J Virol; 2023 Mar; 97(3):e0006323. PubMed ID: 36840558
[TBL] [Abstract][Full Text] [Related]
10. Homologous recombination deficiency real-time clinical assays, ready or not?
Fuh K; Mullen M; Blachut B; Stover E; Konstantinopoulos P; Liu J; Matulonis U; Khabele D; Mosammaparast N; Vindigni A
Gynecol Oncol; 2020 Dec; 159(3):877-886. PubMed ID: 32967790
[TBL] [Abstract][Full Text] [Related]
11. Ovarian cancer-associated mutations disable catalytic activity of CDK12, a kinase that promotes homologous recombination repair and resistance to cisplatin and poly(ADP-ribose) polymerase inhibitors.
Joshi PM; Sutor SL; Huntoon CJ; Karnitz LM
J Biol Chem; 2014 Mar; 289(13):9247-53. PubMed ID: 24554720
[TBL] [Abstract][Full Text] [Related]
12. RB localizes to DNA double-strand breaks and promotes DNA end resection and homologous recombination through the recruitment of BRG1.
Vélez-Cruz R; Manickavinayaham S; Biswas AK; Clary RW; Premkumar T; Cole F; Johnson DG
Genes Dev; 2016 Nov; 30(22):2500-2512. PubMed ID: 27940962
[TBL] [Abstract][Full Text] [Related]
13. Human papillomavirus 16 E2 interaction with TopBP1 is required for E2 and viral genome stability during the viral life cycle.
Prabhakar AT; James CD; Fontan CT; Otoa R; Wang X; Bristol ML; Hill RD; Dubey A; Morgan IM
bioRxiv; 2023 Jan; ():. PubMed ID: 36712128
[TBL] [Abstract][Full Text] [Related]
14. Performance of a RAD51-based functional HRD test on paraffin-embedded breast cancer tissue.
van Wijk LM; Vermeulen S; Ter Haar NT; Kramer CJH; Terlouw D; Vrieling H; Cohen D; Vreeswijk MPG
Breast Cancer Res Treat; 2023 Dec; 202(3):607-616. PubMed ID: 37725154
[TBL] [Abstract][Full Text] [Related]
15. Reversion and non-reversion mechanisms of resistance to PARP inhibitor or platinum chemotherapy in BRCA1/2-mutant metastatic breast cancer.
Waks AG; Cohen O; Kochupurakkal B; Kim D; Dunn CE; Buendia Buendia J; Wander S; Helvie K; Lloyd MR; Marini L; Hughes ME; Freeman SS; Ivy SP; Geradts J; Isakoff S; LoRusso P; Adalsteinsson VA; Tolaney SM; Matulonis U; Krop IE; D'Andrea AD; Winer EP; Lin NU; Shapiro GI; Wagle N
Ann Oncol; 2020 May; 31(5):590-598. PubMed ID: 32245699
[TBL] [Abstract][Full Text] [Related]
16. TOPBP1
Liu Y; Cussiol JR; Dibitetto D; Sims JR; Twayana S; Weiss RS; Freire R; Marini F; Pellicioli A; Smolka MB
J Cell Biol; 2017 Mar; 216(3):623-639. PubMed ID: 28228534
[TBL] [Abstract][Full Text] [Related]
17. Interaction between Rad9-Hus1-Rad1 and TopBP1 activates ATR-ATRIP and promotes TopBP1 recruitment to sites of UV-damage.
Ohashi E; Takeishi Y; Ueda S; Tsurimoto T
DNA Repair (Amst); 2014 Sep; 21():1-11. PubMed ID: 25091155
[TBL] [Abstract][Full Text] [Related]
18. CIP2A Interacts with TopBP1 and Drives Basal-Like Breast Cancer Tumorigenesis.
Laine A; Nagelli SG; Farrington C; Butt U; Cvrljevic AN; Vainonen JP; Feringa FM; Grönroos TJ; Gautam P; Khan S; Sihto H; Qiao X; Pavic K; Connolly DC; Kronqvist P; Elo LL; Maurer J; Wennerberg K; Medema RH; Joensuu H; Peuhu E; de Visser K; Narla G; Westermarck J
Cancer Res; 2021 Aug; 81(16):4319-4331. PubMed ID: 34145035
[TBL] [Abstract][Full Text] [Related]
19. Prexasertib treatment induces homologous recombination deficiency and synergizes with olaparib in triple-negative breast cancer cells.
Mani C; Jonnalagadda S; Lingareddy J; Awasthi S; Gmeiner WH; Palle K
Breast Cancer Res; 2019 Sep; 21(1):104. PubMed ID: 31492187
[TBL] [Abstract][Full Text] [Related]
20. Poly(ADP-ribose) polymerase (PARP) inhibitors for the treatment of ovarian cancer.
Tattersall A; Ryan N; Wiggans AJ; Rogozińska E; Morrison J
Cochrane Database Syst Rev; 2022 Feb; 2(2):CD007929. PubMed ID: 35170751
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
